Patents by Inventor Carlo Alfieri

Carlo Alfieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION
    Publication number: 20170160290
    Abstract: The invention relates to a method for determining whether a renal transplanted patient is at risk of transplant rejection or CAN, comprising a step of determining the expression level of the periostin (POSTN) gene on a renal transplant biopsy obtained from said transplanted patient. The invention also relates to a compound selected from the group consisting of monoclonal anti-CD20 antibodies, anti-thymocyte globulin, proteasome inhibitors, anti-C antibodies, monoclonal anti-CD3 antibodies, glucocorticoids, cytostatics, calcineurin inhibitors and mTOR inhibitors, for use in a method for preventing renal transplant rejection and in CAN development in a transplanted patient determined as being at risk of renal transplant rejection according to a method of the invention.
    Type: Application
    Filed: July 8, 2015
    Publication date: June 8, 2017
    Inventors: Christos CHATZIANTONIOU, Jean-Claude DUSSAULE, Piergiorgio MESSA, Carlo ALFIERI
  • Method for treating infected renal calculosis
    Patent number: 4499107
    Abstract: Pharmaceutical compositions suitable for the therapy of infected renal calculosis, containing propionhydroxamic acid as an active principle, are described.
    Type: Grant
    Filed: October 19, 1982
    Date of Patent: February 12, 1985
    Assignee: Dr. L.sup.o. Zambeletti, S.p.A.
    Inventors: Mario Bergamaschi, Carlo Alfieri